The number of people suffering from metabolic disease worldwide already exceeds one fifth (1/5) of the world’s population and is increasing every year. As a result, the demand for new drugs that people, who fight against chronic metabolic disease, can safely take for a long period of time has been very high.
Recognizing such a demand of the times, NovMetaPharma decided to focus on developing safe and effective medication treating metabolic diseases. Therefore, we are conducting clinical trials not only in South Korea but also in the United States and Australia, and walking through the difficult path of new drug development now. We invest our time and effort with clear confidence because we believe in our new drug substances and technology, meticulous development strategy, and constant challenging spirit.
We know that the path of new drug development that NovMetaPharma has been taking for over the past years is not only our dream but an aspiration of numerous patients and families, who are suffering from metabolic diseases. Therefore, members of NovMetaPharma work with intense concentration and great responsibility in every process and moment of decision.
With the expectations and support from all those who support us, we promise that we will do our best every day and never stop until the day when the long-awaited dream of numerous patients and families come true.